2023
DOI: 10.3389/fphar.2023.1162309
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value and immune-infiltration pattern of FOXD3-AS1 in patients with glioma

Abstract: Gliomas are difficult-to-treat brain tumors due to their aggressive nature, rapid proliferation, and high invasiveness (Zhang et al., J Cell Biochem, 2019, 120 (9), 15106–15118; Ge et al., Int J Biochem Cell Biol, 2021, 139, 106054). FOXD3-AS1 has been identified as an emerging potential target for tumor prediction and treatment in many studies (Qin et al., Front Oncol, 2021, 11, 688027). However, the utility of FOXD3-AS1 has not been reported in glioma patients (Li et al., Cancer Manag Res, 2021, 13, 9037–904… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Given the above, our study emphasizes the urgency to unravel speci c molecular and microenvironmental properties and identify key biomarkers impacting GBM and LGG metabolism. By doing so, we aim to pave the way for more targeted potential therapies [14,15]. To this end, we have developed a prognostic predictive nomogram speci c for brain glioma (GBMLGG) centered around disul dptosis-associated genes.…”
Section: Introductionmentioning
confidence: 99%
“…Given the above, our study emphasizes the urgency to unravel speci c molecular and microenvironmental properties and identify key biomarkers impacting GBM and LGG metabolism. By doing so, we aim to pave the way for more targeted potential therapies [14,15]. To this end, we have developed a prognostic predictive nomogram speci c for brain glioma (GBMLGG) centered around disul dptosis-associated genes.…”
Section: Introductionmentioning
confidence: 99%